Cognitive-behavioral therapy for depression in adolescent girls at risk for type 2 diabetes
Official title: Depression and Insulin Sensitivity in Adolescents
Run by Colorado State University · NCT03263351 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study tests if cognitive-behavioral therapy can help adolescent girls at risk for type 2 diabetes feel less depressed and improve their insulin sensitivity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 17 Years |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Colorado State University Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Trial ID | NCT03263351 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are female adolescents aged 12-17 with a BMI in the 85th percentile or higher and moderate depressive symptoms.
✕Probably not a fit
Patients who are pregnant, have diagnosed type 2 diabetes, or major psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of cognitive-behavioral therapy (CBT) on improving insulin sensitivity and reducing depressive symptoms in adolescent girls aged 12-17 who are at risk for type 2 diabetes. Participants will be divided into a CBT group and a health education control group, with assessments conducted over a one-year follow-up period. The study aims to evaluate changes in eating, physical activity, and sleep patterns as potential mediators of the intervention's effects. The focus is on racially and ethnically diverse girls with moderate depressive symptoms and a family history of type 2 diabetes.
Why it matters
Potential benefit: If successful, this intervention could significantly improve mental health and metabolic outcomes for adolescent girls at risk for type 2 diabetes.
How similar studies have gone: Preliminary studies have shown promise in using cognitive-behavioral therapy to improve depressive symptoms and insulin sensitivity in similar populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female * Age 12-17 years * Body mass index (BMI) ≥85th percentile for age \& sex * Center for Epidemiologic Studies-Depression Scale (CES-D) \>20 * English speaking * ≥1 first- or second-degree family member with type 2 diabetes (T2D), prediabetes, or gestational diabetes * Good general health Exclusion Criteria: * Pregnancy or breastfeeding * Type 2 diabetes as indicated by fasting glucose≥126 mg/dL or 2-hour glucose\>200 mg/dL or Hba1c\>=6.5 * Medication affecting mood, weight, cortisol, or insulin sensitivity, including insulin sensitizers (e.g., metformin), anti-depressants, and stimulants * Major psychiatric disorder that, in the opinion of the investigators, would impede study compliance and necessitate more intensive treatment, including major depressive disorder, bipolar disorder, posttraumatic stress disorder, panic disorder, obsessive-compulsive disorder, schizophrenia, conduct disorder, alcohol and substance abuse, and anorexia/bulimia nervosa * Psychotherapy or structured weight loss program * Active suicidal ideation or suicidal behavior
Where it's running
-
Children's Hospital Colorado
Aurora, Colorado, United States Recruiting
Study contacts
- Study coordinator: Lauren B Shomaker, PhD
- Email: lauren.shomaker@colostate.edu
- Phone: (970)491-3217
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating the impact of a GLP-1 medication on brain insulin response
This study is testing if a medication called semaglutide can change how the brain responds to insulin in people of different weights to see if it helps with thinking and eating habits.
-
Evaluating the best time for resistance exercise to improve insulin sensitivity and sleep
This study is testing whether doing resistance exercises in the morning or evening helps people aged 50-74 with overweight or obesity improve their insulin sensitivity and sleep quality.
-
Endoscopic sleeve gastroplasty for people with obesity and MASH
This study will test whether endoscopic sleeve gastroplasty plus lifestyle changes helps adults with obesity and MASH lose weight and improve liver health compared with lifestyle changes alone.
-
Impact of weight loss on fat tissue signaling in muscles
This study is testing how losing weight affects fat tissue in muscles and whether it helps people with obesity improve their insulin sensitivity.
-
Investigating the links between obesity, insulin resistance, and long COVID
This study is trying to see if obesity and insulin resistance make long-lasting COVID-19 symptoms worse, by looking at fat tissue and its role in inflammation and the virus.
-
Effects of weight loss with and without exercise on metabolic health
This study is testing whether losing weight with exercise helps improve metabolic health more than just losing weight through dieting alone for people with obesity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.